ORCID as entered in ROS

Select Publications
2019, 'Standardized Operational Protocol for Human Brain Banking in China', NEUROSCIENCE BULLETIN, 35, pp. 270 - 276, http://dx.doi.org/10.1007/s12264-018-0306-7
,2019, 'Subtyping of Parkinson’s Disease - Where Are We Up To?', Aging and Disease, http://dx.doi.org/10.14336/AD.2019.0112
,2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies (vol 141, pg 521, 2018)', BRAIN, 141, http://dx.doi.org/10.1093/brain/awy012
,2018, 'Reader response: Diagnosis and management of dementia with Lewy bodys: Fourth consensus report of the DLB Consortium', Neurology, 90, pp. 300, http://dx.doi.org/10.1212/WNL.0000000000004918
,2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies', Brain, 141, pp. 521 - 534, http://dx.doi.org/10.1093/brain/awx328
,2018, 'Dissection of prodromal Alzheimer’s disease', Frontiers in Bioscience Landmark, 23, pp. 1272 - 1291, http://dx.doi.org/10.2741/4643
,2018, 'Mutation screening of the CHCHD2 gene for Alzheimer's disease and frontotemporal dementia in Chinese mainland population', Journal of Alzheimer S Disease, 61, pp. 1283 - 1288, http://dx.doi.org/10.3233/JAD-170692
,2018, 'The correlations between postmortem brain pathologies and cognitive dysfunction in aging and Alzheimer’s disease', Current Alzheimer Research, 15, pp. 462 - 473, http://dx.doi.org/10.2174/1567205014666171106150915
,2018, 'Neuroimaging Advances in Preclinical Alzheimers disease', Neuropsychiatry, 08, http://dx.doi.org/10.4172/neuropsychiatry.1000508
,2017, 'Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment', Plos One, 12, pp. e0179823, http://dx.doi.org/10.1371/journal.pone.0179823
,2017, 'Genetic features of MAPT, GRN, C9orf72 and CHCHD10 gene mutations in Chinese patients with frontotemporal dementia', Current Alzheimer Research, 14, pp. 1102 - 1108, http://dx.doi.org/10.2174/1567205014666170426105713
,2017, 'How does white matter microstructure differ between the vascular and amnestic mild cognitive impairment?', Oncotarget, 8, pp. 42 - 50, http://dx.doi.org/10.18632/oncotarget.13960
,2017, 'Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia', Journal of Alzheimer S Disease, 58, pp. 163 - 170, http://dx.doi.org/10.3233/JAD-161272
,2017, 'SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8', Oncotarget, 8, pp. 1983 - 1992, http://dx.doi.org/10.18632/oncotarget.14077
,2017, 'Book Review: Remark the Book of Landmark Papers in Neurology.', Curr Alzheimer Res, 14, pp. 1348 - 1349, http://dx.doi.org/10.2174/156720501412171030154955
,2017, 'High-sensitivity C-reactive protein in stroke patients - The importance in consideration of influence of multiple factors in the predictability for disease severity and death', JOURNAL OF CLINICAL NEUROSCIENCE, 36, pp. 12 - 19, http://dx.doi.org/10.1016/j.jocn.2016.10.020
,2016, '中国人脑组织库标准化操作方案 (Standardised Operation Procedure for Human Brain Tissue Banking in China)', Acta Anatomica Sinica
,2016, 'ROCK1 is associated with Alzheimer’s disease-specific plaques, as well as enhances autophagosome formation but not autophagic Aβ clearance', Frontiers in Cellular Neuroscience, 10, http://dx.doi.org/10.3389/fncel.2016.00253
,2016, 'MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in Alzheimer's disease', FEBS Letters, pp. 2190 - 2200, http://dx.doi.org/10.1002/1873-3468.12229
,2016, 'MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease', Scientific Reports, 6, http://dx.doi.org/10.1038/srep26697
,2016, 'Quantitative protein profiling of hippocampus during human aging', Neurobiology of Aging, 39, pp. 46 - 56, http://dx.doi.org/10.1016/j.neurobiolaging.2015.11.029
,2016, 'Translational Alzheimer’s disease research', Current Alzheimer Research, 13, pp. 214, http://dx.doi.org/10.2174/156720501303160217102238
,2016, 'Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease', Parkinsonism and Related Disorders, 24, pp. 89 - 94, http://dx.doi.org/10.1016/j.parkreldis.2015.12.018
,2016, 'Editorial: Translational Alzheimer's Disease Research.', Curr Alzheimer Res, 13, pp. 214 - 214, http://dx.doi.org/10.2174/156720501303160217102238
,2015, 'Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)', Neurobiology of Disease, 82, pp. 445 - 454, http://dx.doi.org/10.1016/j.nbd.2015.07.011
,2015, 'Coexistence of High Fibrinogen and Low High-density Lipoprotein Cholesterol Levels Predicts Recurrent Cerebral Venous Thrombosis', CHINESE MEDICAL JOURNAL, 128, pp. 1732 - 1737, http://dx.doi.org/10.4103/0366-6999.159345
,2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', Biomed Research International, 2015, pp. 135674, http://dx.doi.org/10.1155/2015/135674
,2014, 'Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis', Frontiers in Molecular Neuroscience, 7, http://dx.doi.org/10.3389/fnmol.2014.00057
,2014, 'Genetics of hereditary neurological disorders in children', Translational Pediatrics, 3, pp. 109 - 119, http://dx.doi.org/10.3978/j.issn.2224-4336.2014.03.04
,2014, 'Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment', Dementia and Geriatric Cognitive Disorders, 37, pp. 223 - 231, http://dx.doi.org/10.1159/000353541
,2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784
,2013, 'DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue', Neuroscience Bulletin, 29, pp. 649 - 654, http://dx.doi.org/10.1007/s12264-013-1379-y
,2013, 'Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3', CNS Neuroscience and Therapeutics, 19, pp. 688 - 694, http://dx.doi.org/10.1111/cns.12124
,2013, 'Erratum: Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese han population (American Journal of Alzheimer's Disease and Other Dementias (2011) 26:8 (627-630) DOI:10.1177/1533317511432735)', American Journal of Alzheimer S Disease and Other Dementias, 28, pp. 715, http://dx.doi.org/10.1177/1533317513502260
,2013, 'Can we clinically diagnose dementia with Lewy bodies yet?', , pp. 1 - 9, http://dx.doi.org/10.1186/2047-9158-2-4
,2013, 'Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease', Journal of Clinical Neuroscience, 20, pp. 1089 - 1094, http://dx.doi.org/10.1016/j.jocn.2012.09.025
,2013, 'LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models', Journal of Molecular Medicine - Jmm, 91, pp. 513 - 522, http://dx.doi.org/10.1007/s00109-012-0984-y
,2012, 'Metabolomics: A novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease', Neuroscience Bulletin, 28, pp. 641 - 648, http://dx.doi.org/10.1007/s12264-012-1272-0
,2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2
,2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033
,2012, 'High-Sensitivity C-Reactive Protein is a Strong Risk Factor for Death after Acute Ischemic Stroke among Chinese', CNS NEUROSCIENCE & THERAPEUTICS, 18, pp. 261 - 266, http://dx.doi.org/10.1111/j.1755-5949.2012.00296.x
,2012, 'History, present and progress of frontotemporal dementia in China: A systematic review', International Journal of Alzheimer's Disease, 2012, pp. 1 - 6, http://dx.doi.org/10.1155/2012/587215
,2012, 'The potential role of microRNA-146 in Alzheimer's disease: Biomarker or therapeutic target?', Journal of Medical Hypotheses, 78, pp. 398 - 401, http://dx.doi.org/10.1016/j.mehy.2011.11.019
,2011, 'Association study of Clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population', American Journal of Alzheimers Disease and Other Dementias, 26, pp. 627 - 630, http://dx.doi.org/10.1177/1533317511432735
,2011, 'Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease', ACTA Neuropathologica, 121, pp. 695 - 704, http://dx.doi.org/10.1007/s00401-011-0815-1
,2011, 'Clincial correlates of similar pathologies in Parkinsonian syndromes', Movement Disorders, 26, pp. 499 - 506, http://dx.doi.org/10.1002/mds.23336
,2011, 'Clinical phenotypes in autopsy-confirmed pick disease', Neurology, 76, pp. 253 - 259, http://dx.doi.org/10.1212/WNL.0b013e318207b1ce
,2011, 'Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease', Current Alzheimer Research, 8, pp. 765 - 770, http://dx.doi.org/10.2174/156720511797633232
,2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027
,2011, 'Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease', Dementia and Geriatric Cognitive Disorders, 31, pp. 349 - 357, http://dx.doi.org/10.1159/000328165
,